This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

SciClone Pharmaceuticals (SCLN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 85.80M 84.23M 66.65M 53.02M
Receivables 40.01M 38.11M 42.23M 30.67M
Inventories 15.24M 10.42M 8.81M 7.08M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 143.41M 137.33M 121.07M 95.95M
Property, Plant & Equipment, Gross 3.95M 3.90M 2.90M 2.33M
Accumulated Depreciation & Depletion 3.11M 2.53M 1.92M 1.74M
Property, Plant & Equipment, Net 843.00K 1.38M 984.00K 588.00K
Intangibles 0.00 0.00 45.18M 53.00K
Other Non-Current Assets 242.00K 683.00K 1.11M 1.22M
Total Non-Current Assets 36.82M 36.74M 79.26M 1.86M
Liabilities & Shareholder Equity
Total Assets 180.23M 174.07M 200.33M 97.81M
Accounts Payable 7.19M 7.79M 5.59M 3.88M
Short Term Debt 1.65M 1.44M 2.50M 0.00
Other Current Liabilities 5.03M 4.41M 3.27M 0.00
Total Current Liabilities 33.59M 30.81M 25.28M 12.13M
Long Term Debt 0.00 0.00 0.00 2.50M
Deferred Income Taxes 0.00 0.00 8.72M 0.00
Other Non-Current Liabilities 44.00K 237.00K 15.87M 990.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 44.00K 237.00K 24.58M 3.49M
Total Liabilities 33.63M 31.05M 49.87M 15.62M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 146.60M 143.02M 150.46M 82.19M
Common Par 52.00K 54.00K 58.00K 48.00K
Additional Paid In Capital 278.33M 274.39M 266.91M 225.90M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -135.96M -134.41M -118.85M -143.82M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 4.18M 2.99M 2.34M 67.00K
Total Capitalization 146.60M 143.02M 150.46M 84.69M
Total Equity 146.60M 143.02M 150.46M 82.19M
Total Liabilities & Stock Equity 180.23M 174.07M 200.33M 97.81M
Total Common Shares Outstanding 52.37M 54.48M 57.85M 48.01M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 53.59M 56.64M 55.11M 47.62M
Diluted Weighted Shares Outstanding 54.94M 58.48M 57.39M 49.41M
Number of Employees 570 870 875 261
Number of Part-Time Employees 0 0 0 0
SCLN News

SCLN SciClone Pharmaceuticals

Analysts Ratings for SCLN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SCLN ANALYST REPORT

Brokerage Partners

SCLN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs